A coustic waves and their properties have been utilized for scientific exploration and manipulation for years. After World War I (1914) (1915) (1916) (1917) (1918) , echo-sounding devicesprimitive sonar systems-began to measure ocean depth by recording the time it took for a sound signal from the ship to bounce off the ocean floor and return. 1 In 1953, Donald Staggs, an electrical engineer working for the Illinois State Water Survey, used Doppler radar to record the first observation of an echo pattern associated with a tornadic thunderstorm. 2 As the years and technology progressed, so did the precision of acoustic waves. Developed in the 1980s, Extracorporeal Shockwave Lithotripsy used focused acoustic waves to break apart kidney stones within the body. Prior to its development, the only way to remove kidney stones was through surgery. 3 Adapting the same principles behind Extracorporeal Shockwave Lithotripsy, Adaptive Focused Acoustics (AFA) uses high-frequency acoustic waves to deliver "tunable" acoustic waves through water into various solutions. The first applications to pharmaceutical research and development revolved around tissue homogenization and RNA extraction. 4 A few years later, after a strong push toward a more high-throughput automated environment and a lack of high-throughput sonication or vortex instruments, Compound Management saw the possibility of using AFA to reduce dissolution time and variability and to standardize dissolution methods. Its ability to improve compound solubility would result in higher quality biological assay data and true pIC 50 potencies. Around this same time, the only other high-throughput system was the SonicMan TM (Matrical Bioscience, Spokane, WA), which uses sample-submerged pins to dissolve samples. 5 Prior to the introduction of AFA to Compound Management, samples were typically mixed using either vortex or wet sonication methods. Audible acoustic waves vibrate between 20 Hz to 20 kHz. 6 Adaptive Focused Acoustics, however, vibrates at 500 kHz. When placed within a water bath, acoustic waves can be focused to a point the size of a pinhead, allowing for a noncontact isothermal method that can accommodate open or closed containers. Therefore, by focusing the waves into the bottom or center of a sample container, intense agitation occurs, inducing sample dissolution. More specifically, dissolution is achieved by cycling quick acoustic pulses toward a focused point within a sample container. This quick pulsing action mixes a solution by creating cavitation bubbles that form and collapse repeatedly, producing "jets" of water that move at speeds greater than 100 m/s. 7 In this report, 3 AFA systems manufactured by Covaris (Woburn, MA) were investigated: the Automated Acoustic Mixer (AAM), the Stand Alone Acoustic Mixer (SAAM), and the Microtiter Plate Acoustic Mixer (MPAM). The AAM was the first system designed specifically for Compound Management. It aids in the solubilization of solids into DMSO solutions by incorporating pick and place robotics with a transducer and water bath. It can handle 384 × 4-mL glass vials without human intervention, making it suitable for large-volume high-throughput processing. The SAAM contains only a transducer and water bath. It can handle 16 × 4-mL glass vials or 96 × 1-mL tubes at a time and is suitable for lower throughput operations. The MPAM is the newest of the acoustic mixers and is able to mix samples within a 96-, 384-, or 1536-well plate. It can only mix one plate at a time, but its line transducer allows column-to-column mixing instead of well-to-well or vial-to-vial processing found in the other 2 systems with the more traditional round transducer.
The 3 instruments were evaluated for their applications to appropriate Compound Management processes and, where possible, compared to more traditional approaches. Systems were analyzed over a 2-year period as AFA technologies and transducers developed. Aspects that were assessed included reduction in processing times and improvements in the quality and solubility of the samples produced. All systems were appraised for their potential benefits to Compound Management processes at GlaxoSmithKline (GSK).
MATERIALS AND METHODS

Materials
Compounds. Salbutamol sulfate 99% (Cat # 51022-70-9) (Avocado Research Chemicals Ltd., United Kingdom) and chloroquine (Cat # 200-055-2) (Sigma-Aldrich, St. Louis, MO) were the main chemicals used in determining the ability of the systems. All other samples tested for sample degradation and biological activity were from the GSK library. Analytical processes. Liquid Chromatography-Electrospray Mass Spectrometry (LC-MS) was used to determine the identity and purity of the compounds. Chemiluminescence Nitrogen Detection (CLND) was the technique used for concentration determination. 8 The instrument response was calibrated daily using caffeine, and a standard solution of 10 mM ondansetron was used to ensure reliability of results. Nuclear Magnetic Resonance (NMR) was also used for purity, identity, and concentration determination.
Instruments
Methods
Automated Acoustic Mixer (AAM). The AAM system was developed to automate the solubilization of compounds into DMSO stock solutions. This is a fundamental process for all Compound Management organizations. Three specific experiments were conducted with the AAM. The first experiment established appropriate treatment times, the second experiment compared AFA with traditional methods of solubilization, namely sonication and vortexing, and the third experiment evaluated sample stability.
In experiment 1, defining treatment times, 400 capped samples stored in 4-mL glass vial samples were subjected to 20 seconds of acoustic power. Sample selection was based on sample clarity immediately after dissolution. Afterward, samples were visually inspected for liquid clarity, and observations were recorded.
In experiment 2, the AAM was compared to wet sonication and vortexing using both a low-soluble compound, salbutamol sulfate 99%, and an insoluble compound, chloroquine. Salbutamol sulfate 99% and chloroquine were each dissolved with neat DMSO into seven 4-mL glass vials to a targeted 10-mM concentration. Each salbutamol sample was subjected to a different treatment: 20-and 60-second vortex, 20-second AFA, and 20-, 60-, 300-, and 600-second wet sonication.
Similarly, chloroquine samples were subjected to a different treatment: 20-, 40-, 60-, 80-, and 100-second AFA, 100-second vortex, and 100-second wet sonication. Aliquot samples of 120 µL were taken from all samples, plated into Greiner clear 96 polypropylene plates, and submitted for NMR analysis for concentration and purity measurements.
Dissolution on the AAM is achieved through vigorous sample agitation. This agitation has the potential to break down sample composition and cause sample degradation. In experiment 3, the effect of AFA on sample stability was determined. Fourteen potentially unstable or heat-sensitive GSK samples were subjected to 5 conditions: no treatment, AFA, wet sonication, 24-hour incubation at 23 °C, and 24-hour incubation at 41 °C, to see if the samples would degrade. Each sample was weighed 5 times into 4-mL glass vials and dissolved to 1 mL at 10 mM using neat DMSO. Aliquot samples were immediately submitted for LC-MS analysis by plating 1 µL of each sample into Greiner clear 96 polypropylene V-bottom plates and diluting it to 50 µL with neat DMSO. The remaining samples were subjected to their treatments. The AFA samples were mixed for 20 seconds and then plated as before. Wet sonication samples were sonicated for 20 minutes and plated like before.
Stand Alone Acoustic Mixer (SAAM). Although the SAAM was originally developed for compound solubilization in glass vials, tests determined that it could also accommodate 1-mL bar-coded Abgene tubes. This accommodation changes the potential applications for AFA because the treatment can be applied to samples already in solution in tubes. Potential applications include thawing of solutions in tubes, the ability to remix and resolubilize precipitated solutions, and the effects of AFA mixing on biological potency. Three experiments were run on the SAAM to explore these aspects.
The first SAAM experiment examined the time it took to thaw samples in Abgene tubes by AFA. One, 5, 20, and 50 Abgene 1-mL bar-coded tubes set inside their accompanied tube rack were filled with 500 µL of neat DMSO. Using the SAAM manufacturer's predefined settings, each tube was subjected to a 2-second AFA pulse. Abgene 1-mL bar-coded tubes cannot be exposed to AFA for longer than 2 seconds, as significant heat can be produced and damage to the tube or sample can occur. One 2-second AFA pulse per tube within a tube rack equals one sweep cycle. Multiple sweep cycles are necessary to achieve AFA benefits. Times were recorded for each tube integral after 1, 2, 3, 4, and 5 cycles.
During sample storage, samples have the potential to precipitate. Samples stored in vials are routinely mixed, but samples stored in Abgene 1-mL bar-coded tubes are not. Typically, GSK samples held in tubes at 4 °C are removed from stores and thawed via convection heating prior to being loaded onto liquid-handling instruments for dispensing. The second SAAM experiment was set up to determine whether AFA adds value by redissolving precipitated samples. Thirty-five precipitated samples stored in tubes at 10 mM were selected for AFA treatment. They were selected at random from a group of lead optimization samples, providing they showed visual evidence of precipitation. As the control for this experiment and following normal process protocols, the frozen precipitated samples were thawed using a heater, and an aliquot sample of 50 µL was plated into a Greiner clear 96 polypropylene V-bottom plate. Samples were then returned to the freezer to refreeze. Once the samples were frozen, they were placed on the SAAM for 5 × 2-second cycles. Aliquot samples of 50 µL were plated into a Greiner clear 96 polypropylene V-bottom plate. Both 96-well plates were submitted for CLND analysis for sample concentration determination.
Adaptive Focused Acoustics has the potential of maximizing sample biological activity by ensuring homogenous samples. To test this in experiment 3, 61 samples at 10 mM were treated as described for the previous experiment, and plates were submitted for CLND analysis. The 100-nL aliquot samples were also plated in NUNC 384 polystyrene plates and submitted for in-house biological testing.
Microtiter Plate Acoustic Mixer (MPAM). The previous 2 acoustic systems achieved mixing by using a circular transducer. This enables the transducer to focus to a point the size of a pinhead. The MPAM, however, uses a line transducer, which focuses the acoustic power into a line that applies energy the length of a plate column. Using this system, 4 experiments were run: defining plate and seal preferences, low-and highvolume sample reconstitution, and plate mixing.
The first MPAM experiment determined ideal seal and plate types. A range of commonly used plates were filled with neat DMSO in columns 1 to 12 and sealed with different seals. Table 1 describes the plate, seal, and DMSO volume combinations that were tested. The AFA treatment times as well as plate and seal conditions were recorded.
During plate storage and shipping, evaporation of low-volume samples is a common issue. One way to prevent evaporation effects is to dry down samples and reconstitute them later. Samples can be brought back into solution by adding neat DMSO and shaking the plate for a set amount of time. With the line transducer, the MPAM is also able to achieve this "mix and reconstitute" function. Experiments were performed to test both low-and high-volume sample reconstitution.
To test low-volume sample reconstitution, two hundred seventy-four 1-mM compounds of known biological activity were dispensed at 50 nL into 6 Greiner white 384 polystyrene low-volume plates. After the plates were allowed to dry for 96 hours, 50 nL of neat DMSO and 2.5 µL of assay-specific enzyme solution were added to each plate. The plates were then sealed with foil-adhesive seals, briefly centrifuged for 20 seconds, and then split into 3 groups of 2. Two plates were centrifuged for 1 minute at 1000 rpm (1486g), 2 plates were shaken on a Combi shaker for 30 seconds, and the remaining 2 plates were placed on the MPAM for one mix cycle. All 6 plates were briefly centrifuged once more to ensure any splashed sample was removed from the seals. Plates were then submitted for in-house biological analysis.
The high-volume sample reconstitution experiment followed the same pattern as the experiment above, with a few differences. Six Labcyte clear 384 LDV diamond well COC plates were filled with 400 nL at 10 mM of the same samples selected above and dried down for 1 week. Two additional plates at 50 nL were made and submitted for testing as the control. After 1 week, 4 µL of neat DMSO was added to the plate to provide a suitable mixing volume and bring the sample concentration to 1 mM. Plates were sealed with foil-adhesive seals and split into 3 groups of 2 as before. Two plates were centrifuged for 1 minute at 1000 rpm (1486g), 2 plates were shaken on a Combi shaker for 30 seconds, and the last 2 plates were placed on the MPAM for one mix cycle. All 6 plates were briefly centrifuged once more to ensure any splashed sample was removed from the seals. Each plate was then copied into Greiner white 384 polystyrene low-volume plates and submitted for in-house biological analysis.
The fourth MPAM experiment looked at mixing plates before biological testing to measure any benefit specifically for samples known to precipitate in DMSO solutions. Thirty-four samples known to precipitate were dissolved to 10-mM solutions in 4-mL glass vials. One hundred microliters of each sample was then transferred into 5 Greiner clear 384 deep well plates. The plates were sealed with Abgene heat seals and allowed to sit for 1 week at room temperature to promote precipitation. One extra plate at 50 µL was made in a Greiner clear 384 polypropylene V-bottom plate and submitted for initial CLND concentration analysis. After 1 week, the 5 plates were subjected to 5 different treatments: 1 was not treated at all, 1 was shaken on a Combi shaker for 30 seconds, and the remaining 3 were mixed in the MPAM for 1, 2, and 3 cycles. All plates underwent a brief centrifuge to ensure any splashed sample was removed from the seals. The seals were then removed, and 50-uL aliquot samples were drawn from the top of the well and dispensed into Greiner clear 384 polypropylene V-bottom plates. The plates were then submitted for CLND analysis to determine sample concentration.
RESULTS AND DISCUSSION
Automated Acoustic Mixer (AAM)
Three experiments were run on the AAM: treatment time, a comparison with conventional solubilization techniques, and sample stability. In experiment 1, treatment times were defined by visually inspecting the clarity of 400 samples after a 20-second mix period. After that mix period, 85% of the samples had gone into solution, and the remaining samples were converted into a fine suspension that could be handled by any liquid-handling system or pipette. Previously, high-throughput sample processing time was 24 hours regardless of the number of samples being processed. The AAM implementation would reduce processing time from 24 hours to 8 hours (or by 67%) for 384 samples.
In order to ascertain how the AAM compares with vortexing and wet sonication, salbutamol sulfate 99% and chloroquine were dissolved and mixed on each system for a certain amount of time. The samples were submitted for CLND analysis in order to determine their final concentrations. Results showed that AAM treatment resulted in a salbutamol sulfate concentration of 10.5 mM (target concentration was 10 mM). Vortexing was able to achieve the same target at 10.5 mM for both times. Wet sonication concentrations ranged from 7.5 to 10.1 mM depending on the length of treatment time. Figure 1 shows the range of concentrations achieved by the different mixing systems.
Similarly, the AAM was compared against vortexing and wet sonication in their abilities to dissolve chloroquine, an insoluble sample. Depending on the AAM mix time, the concentration of chloroquine rose from 0.2 to 2.1 mM. Vortexing for 100 seconds resulted in a concentration of 0.1 mM, and 100-second wet sonication resulted in a concentration of 0.8 mM. Figure 2 illustrates a chart of the results.
In experiment 3, maintaining sample stability was also examined on the AAM as compared to wet sonication and dissolution using heat and/or time. Purity of the LC-MS sample was compared to initial samples. Degradation was determined using the percentage purity difference between time zero and the compounds at the subsequent time points. It is defined as any sample with a purity difference of ≥10%, as this value takes into account any measurement variation within the analysis. As depicted in Figure 3 , sample degradation was seen primarily in samples stored for 24 hours at 41 °C. Only sample 14 showed sample degradation during all treatments. Using a range of selected in-house compounds and standard compounds (salbutamol sulfate 99% and chloroquine), the AAM experiments clearly show an advantage over vortexing or wet sonication. The AAM is capable of achieving target concentrations for difficult-to-dissolve samples 30 times faster than wet sonication (Fig. 1) while maintaining sample integrity (Fig. 3) . Further testing showed that the AAM was 60 times more effective in sample dissolution than wet sonication. It is also able to solubilize samples into partial solution during longer treatment times (Fig. 2) .
Stand Alone Acoustic Mixer (SAAM)
Three experiments were run on the SAAM. The first experiment examined the time taken to thaw tubes via AFA. The time it took to thaw 1, 5, 20, and 50 tubes at 1, 2, 3, 4, and 5 cycles was recorded and plotted. Using the slope of the line, timings were then estimated for runs ranging from 1 to 88 tubes. Current tube thaw practices take 20 minutes per 8-tube racks. Based on an interpolation/extrapolation from the gathered data, it would take 33 minutes to thaw a tube rack containing 80 tubes. Normally, it would take 40 minutes to thaw the same size rack, but current thaw stations contain 8 heaters, allowing 8 racks to be thawed at once. The system's inability to handle multiple racks at a time makes it difficult to justify its use.
Having determined little value in terms of reduced timings, experiment 2 was designed to measure if AFA adds value by redissolving precipitated samples back into solution. For the 35 samples used in the study, the CLND concentrations of samples in the "no mix" control treatment were plotted against samples that were mixed on the SAAM in an orthogonal regression plot. The calculated correlation coefficient was 0.89. A correlation coefficient value greater than 0.81 concludes that the SAAM had no effect on the concentration of precipitated samples as compared to the standard "no mix" methods. Experiment 3 studied the effect of AFA on biological potency. The DMSO sample solutions stored in tubes were either mixed or not mixed on the SAAM and submitted for biological analysis. The pIC 50 values for AFA-treated and -untreated samples were plotted against one another in an orthogonal regression. The resulting correlation coefficient equaled 0.92. Like the precipitation experiment before, the resulting correlation coefficient indicates that there is no difference between the 2 treatment types and that the SAAM adds no value to precipitated samples or to their biological activity.
Microtiter Plate Acoustic Mixer (MPAM)
The 4 experiments on the MPAM were designed to determine plate and seal compatibility, ability of AFA to reconstitute samples in low and high volumes, and potential benefits on sample concentration. The compatibility tests indicated that polypropylene plates work best because heat seals adhere tightly; however, the settings must be reduced to avoid damage to the bottom of the plates. Secondly, polystyrene plates work with foil seals, but well volume must be at half its maximum. Thirdly, adhesive seals do not work on any plate type, and using them can promote carryover. Because the plates must be sealed during mixing, it is a concern that so many plate/seal combinations did not work. From these results, the MPAM can only safely be used at high settings on Greiner polypropylene V-bottom plates with heat seals. Sample reconstitution was tested by drying down dissolved samples and readding DMSO to the wells. Plates were mixed on the MPAM or Combi shaker, centrifuged, or not mixed as the control. Sample activity returned from biological testing was reported in percentage inhibition values. Samples were compared to nondried-down controls and plotted using Spotfire DecisionSite. Plots confirmed that the nondried-down sample control group had higher activity than the reconstituted samples. Sample reconstitution via AFA had the same result as the other treatments, with more than 50% of the samples showing significantly less activity. Figure 4 illustrates that AFA was also ineffective in reconstituting high-volume compound samples. This was disappointing, as preliminary in-house studies using fluorescent dyes had shown some positive results. The behavior of a small range of dyes dissolved in water is not representative of a broad range of discovery compounds dissolved in DMSO.
In the fourth MPAM experiment, the benefits of plate mixing on the MPAM versus conventional methods were investigated using samples known to precipitate. Dissolved samples were stored in conditions likely to cause precipitation and then subjected to various mixing techniques. Figure 5 shows that the concentration of the samples selected did not vary from their initial concentrations as long as the samples were mixed. Results also indicate that mixing type, plate shaking, or AFA are equally effective in redissolving precipitated samples.
CONCLUSION
From the experiments ran on all 3 systems, it is important to note that only the AAM added any significant value to Compound Management's processes. Results showed that it was superior to vortex or wet sonication dissolution methods and that it was able to reduce mixing time to 10 seconds. Following system testing, the AAM was deployed as a standard operating procedure for the dissolution of compounds at all GSK Compound Management sites. It allowed for a more efficient workflow due to its "hands free" operation and eliminated human errors. In addition, the introduction of this system in October 2006 has led to a marked reduction of samples requiring longer vortexing or wet sonication times, as well as reducing the number of samples impacted by incomplete compound dissolution. In the 3 months prior to its implementation, 263 out of 3677 samples processed either did not go into solution after an initial 10-second vortex or did not go into solution at all after a second treatment. This equates to 7.1% of the samples processed. After AAM was introduced, the percentage of difficult-to-dissolve or insoluble samples dropped to 1.1%. Figure 6 illustrates this marked decline.
An analysis of the concentration ranges achieved for lead optimization samples before and after AFA implementation showed the technology was also effective in increasing the overall concentration of samples closer to the targeted 10-mM concentration. As seen in Figure 7 , binned sample concentrations shifted from an average 6-to 8-mM concentration to 8 to 10 mM once the AAM was in full production. Further statistical analysis measuring the differences of proportions confirmed that there was a statistically significant change in concentration before and after the introduction of AFA. The p-values indicate that the only nonsignificant shift in concentrations was in the 0-to 2-mM binned category.
No cost benefit was established for the 2 other AFA systems as compared to existing processes. Consequently, neither instrument has been deployed in GSK Compound Management operations. It will be important to evaluate any new opportunities for AFA as the business evolves and as the technology and instruments mature. The evaluation of AFA in this article demonstrates the importance of applying new technology to the appropriate process and the benefits of thorough analysis and investigation. 12   15   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33 
